215 related articles for article (PubMed ID: 15634211)
1. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
2. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
Tardif M; Mery L; Brouchon L; Boulay F
J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
[TBL] [Abstract][Full Text] [Related]
3. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
4. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
Van Epps DE; Simpson S; Bender JG; Chenoweth DE
J Immunol; 1990 Feb; 144(3):1062-8. PubMed ID: 2295813
[TBL] [Abstract][Full Text] [Related]
5. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells.
Prossnitz ER; Quehenberger O; Cochrane CG; Ye RD
J Immunol; 1993 Nov; 151(10):5704-15. PubMed ID: 8228256
[TBL] [Abstract][Full Text] [Related]
6. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
7. Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin.
Miettinen HM; Gripentrog JM; Jesaitis AJ
J Cell Sci; 1998 Jul; 111 ( Pt 14)():1921-8. PubMed ID: 9645940
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
9. Generation of chimeric C5a/formyl peptide receptors: towards the identification of the human C5a receptor binding site.
Pease JE; Burton DR; Barker MD
Eur J Immunol; 1994 Jan; 24(1):211-5. PubMed ID: 8020557
[TBL] [Abstract][Full Text] [Related]
10. The chemoattractant receptors FPR and C5aR: same functions--different fates.
Boulay F; Rabiet MJ
Traffic; 2005 Feb; 6(2):83-6. PubMed ID: 15634209
[No Abstract] [Full Text] [Related]
11. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
[TBL] [Abstract][Full Text] [Related]
12. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of N-formyl peptide receptors in human bone marrow-derived mesenchymal stem cells.
Viswanathan A; Painter RG; Lanson NA; Wang G
Stem Cells; 2007 May; 25(5):1263-9. PubMed ID: 17234990
[TBL] [Abstract][Full Text] [Related]
14. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
15. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional role of formyl peptide receptor in human bone marrow-derived mesenchymal stem cells.
Kim MK; Min do S; Park YJ; Kim JH; Ryu SH; Bae YS
FEBS Lett; 2007 May; 581(9):1917-22. PubMed ID: 17442310
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil chemoattractant receptors and the membrane skeleton.
Klotz KN; Jesaitis AJ
Bioessays; 1994 Mar; 16(3):193-8. PubMed ID: 8166673
[TBL] [Abstract][Full Text] [Related]
19. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
[TBL] [Abstract][Full Text] [Related]
20. Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils.
Svensson L; Redvall E; Johnsson M; Stenfeldt AL; Dahlgren C; Wennerås C
J Leukoc Biol; 2009 Aug; 86(2):327-36. PubMed ID: 19414538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
